ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Re: Intravesical Nadofaragene Firadenovec Gene Therapy for BCG-unresponsive Non-muscle-invasive Bladder Cancer: A Single-arm, Open-label, Repeat-dose Clinical Trial
European Urology
◽
10.1016/j.eururo.2021.01.027
◽
2021
◽
Author(s):
Francesco Soria
◽
Paolo Gontero
Keyword(s):
Clinical Trial
◽
Gene Therapy
◽
Bladder Cancer
◽
Invasive Bladder Cancer
◽
Repeat Dose
◽
Open Label
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
Related Documents
Cited By
References
Faculty Opinions recommendation of Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.739122585.793581022
◽
2020
◽
Author(s):
Otto Hemminki
Keyword(s):
Clinical Trial
◽
Gene Therapy
◽
Bladder Cancer
◽
Invasive Bladder Cancer
◽
Repeat Dose
◽
Open Label
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
The Lancet Oncology
◽
10.1016/s1470-2045(20)30540-4
◽
2021
◽
Vol 22
(1)
◽
pp. 107-117
◽
Cited By ~ 2
Author(s):
Stephen A Boorjian
◽
Mehrdad Alemozaffar
◽
Badrinath R Konety
◽
Neal D Shore
◽
Leonard G Gomella
◽
...
Keyword(s):
Clinical Trial
◽
Gene Therapy
◽
Bladder Cancer
◽
Invasive Bladder Cancer
◽
Repeat Dose
◽
Open Label
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
Re: Intravesical Nadofaragene Firadenovec Gene Therapy for BCG-unresponsive Non-muscle-invasive Bladder Cancer: A Single-arm, Open-label, Repeat-dose Clinical Trial
European Urology
◽
10.1016/j.eururo.2021.02.015
◽
2021
◽
Author(s):
Markus Grabbert
◽
Roland Seiler
◽
Christian Gratzke
Keyword(s):
Clinical Trial
◽
Gene Therapy
◽
Bladder Cancer
◽
Invasive Bladder Cancer
◽
Repeat Dose
◽
Open Label
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
Results of the phase-I open-label clinical trial SAKK 06/14 assessing safety of intravesical instillation of the recombinant BCG VPM1002BC in patients with non-muscle invasive bladder cancer and previous failure to conventional BCG therapy
European Urology Supplements
◽
10.1016/s1569-9056(18)31563-x
◽
2018
◽
Vol 17
(2)
◽
pp. e1050
◽
Cited By ~ 5
Author(s):
C. Rentsch
◽
P. Bosshard
◽
G. Mayor
◽
M. Rieken
◽
H. Püschel
◽
...
Keyword(s):
Clinical Trial
◽
Bladder Cancer
◽
Phase I
◽
Intravesical Instillation
◽
Invasive Bladder Cancer
◽
Open Label
◽
Muscle Invasive Bladder Cancer
◽
Bcg Therapy
◽
Muscle Invasive
◽
Recombinant Bcg
Download Full-text
Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy
OncoImmunology
◽
10.1080/2162402x.2020.1748981
◽
2020
◽
Vol 9
(1)
◽
pp. 1748981
◽
Cited By ~ 3
Author(s):
Cyrill A. Rentsch
◽
Piet Bosshard
◽
Grégoire Mayor
◽
Malte Rieken
◽
Heike Püschel
◽
...
Keyword(s):
Clinical Trial
◽
Bladder Cancer
◽
Phase I
◽
Intravesical Instillation
◽
Invasive Bladder Cancer
◽
Bacillus Calmette Guerin
◽
Open Label
◽
Muscle Invasive Bladder Cancer
◽
Bcg Therapy
◽
Muscle Invasive
Download Full-text
A phase I open label dose‐escalation study to evaluate the tolerability, safety and immunological efficacy of sub‐urothelial durvalumab injection in adults with muscle‐invasive or high‐risk non‐muscle‐invasive bladder cancer (SUBDUE‐1, SUB‐urothelial DUrvalumab injection‐1 study): clinical trial protocol
BJU International
◽
10.1111/bju.15365
◽
2021
◽
Author(s):
Andrew Moe
◽
Elizabeth Liow
◽
Andrew Redfern
◽
Nicole Swarbrick
◽
Tom Ferguson
◽
...
Keyword(s):
Clinical Trial
◽
Bladder Cancer
◽
High Risk
◽
Phase I
◽
Trial Protocol
◽
Open Label
◽
Muscle Invasive Bladder Cancer
◽
Dose Escalation Study
◽
Label Dose
◽
Muscle Invasive
Download Full-text
The effect of a neoadjuvant instillation of chemotherapy in the prevention of recurrences of non-muscle invasive bladder cancer. Preliminary results of the PRECAVE prospective, controlled, randomized clinical trial
European Urology
◽
10.1016/s0302-2838(21)01132-5
◽
2021
◽
Vol 79
◽
pp. S1043-S1044
Author(s):
D.M. Carrión Monsalve
◽
J. Gomez Rivas
◽
C.R. Trelles
◽
C. Ballesteros Ruiz
◽
M. Alvarez-Maestro
◽
...
Keyword(s):
Clinical Trial
◽
Bladder Cancer
◽
Randomized Clinical Trial
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Preliminary Results
◽
Muscle Invasive
Download Full-text
Diagnostic performance of the Bladder EpiCheck methylation test and photodynamic diagnosis-guided cystoscopy in the surveillance of high-risk non-muscle invasive bladder cancer: A single centre, prospective, blinded clinical trial
Urologic Oncology Seminars and Original Investigations
◽
10.1016/j.urolonc.2021.11.001
◽
2021
◽
Author(s):
Giovanni Cochetti
◽
Jacopo Adolfo Rossi de Vermandois
◽
Vincenza Maulà
◽
Luigi Cari
◽
Rosy Cagnani
◽
...
Keyword(s):
Clinical Trial
◽
Bladder Cancer
◽
High Risk
◽
Diagnostic Performance
◽
Invasive Bladder Cancer
◽
Photodynamic Diagnosis
◽
Single Centre
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
The benefit of a neoadjuvant instillation of chemotherapy in non-muscle invasive bladder cancer: interim analysis of the PRECAVE randomized clinical trial.
10.37554/en-j.arch.esp.urol-20210704-3511-30
◽
2021
◽
Author(s):
Diego Carrión
◽
Juan Gómez Rivas
◽
Cristina Ballesteros Ruiz
◽
Mario Álvarez-Maestro
◽
Emilio Ríos González
◽
...
Keyword(s):
Clinical Trial
◽
Bladder Cancer
◽
Randomized Clinical Trial
◽
Interim Analysis
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial
European Urology Focus
◽
10.1016/j.euf.2018.02.005
◽
2019
◽
Vol 5
(5)
◽
pp. 849-852
Author(s):
Peter F.A. Mulders
◽
Luis Martínez-Piñeiro
◽
Axel Heidenreich
◽
Marko Babjuk
◽
Marc Colombel
◽
...
Keyword(s):
Clinical Trial
◽
Bladder Cancer
◽
Lessons Learned
◽
Invasive Bladder Cancer
◽
Phase 2
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close